Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide
ConclusionMRI with pre-administered SPIO is useful for determining the AM precisely, and an AM of ≥ 2 mm is recommended for curative RFA.Trial registration numberThis study was registered with UMIN Clinical Trials Registry (UMIN 000025406).
Source: Japanese Journal of Radiology - Category: Radiology Source Type: research
More News: Cancer & Oncology | Carcinoma | Clinical Trials | Hepatocellular Carcinoma | Iron | Japan Health | Liver Cancer | MRI Scan | Radiology | Study | Urology & Nephrology